W Scott Harmsen
Overview
Explore the profile of W Scott Harmsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
147
Citations
4955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Owen D, Harmsen W, Ahmed S, Petersen I, Haddock M, Ma D, et al.
Pract Radiat Oncol
. 2024 Dec;
PMID: 39725127
Objectives: Spatially fractionated radiation therapy (SFRT) intentionally delivers a heterogeneous dose distribution characterized by alternating regions of high and low doses throughout a tumor. This modality may enhance response to...
2.
Keegan B, Messina S, Hanson D, Holmes D, Camp J, Sechi E, et al.
AJNR Am J Neuroradiol
. 2024 May;
45(7):943-950.
PMID: 38754997
Background And Purpose: Progressive MS is typically heralded by a myelopathic pattern of asymmetric progressive motor weakness. Focal individual "critical" demyelinating spinal cord lesions anatomically associated with progressive motor impairment...
3.
Foote R, Harmsen W, Amundson A, Carr A, Gamez M, Garces Y, et al.
Cancers (Basel)
. 2024 Jan;
16(2).
PMID: 38254837
Background: Approximately 75% of all head and neck cancer patients are treated with radiotherapy (RT). RT to the oral cavity results in acute and late adverse events which can be...
4.
Dunleavy K, Santiago P, Forde G, Harmsen W, McKenna N, Coelho-Prabhu N, et al.
Inflamm Bowel Dis
. 2023 Dec;
30(11):1935-1945.
PMID: 38142126
Background: Patients with inflammatory bowel disease (IBD) and primary sclerosing cholangitis (PSC) frequently undergo restorative proctocolectomy with ileal pouch-anal anastomosis (IPAA) for medically refractory disease or colonic dysplasia/neoplasia. Subtotal colectomy...
5.
BouSaba J, Torres M, Dilmaghani S, Harmsen W, Ling L, Camilleri M
Gastroenterology
. 2023 Apr;
165(2):499-501.e4.
PMID: 37084852
No abstract available.
6.
Soontrapa P, Dyck P, Dyck P, Klein C, Engelstad J, Davies J, et al.
J Peripher Nerv Syst
. 2023 Apr;
28(2):191-201.
PMID: 37017656
Background And Aims: Comprehensive study of sural nerve biopsy utility based on individual histopathologic preparations is lacking. We aimed to quantify the value of different histologic preparations in diagnosis. Methods:...
7.
Sannaa W, Dilmaghani S, BouSaba J, Maselli D, Atieh J, Eckert D, et al.
Diabetes Obes Metab
. 2022 Oct;
25(2):377-386.
PMID: 36193713
Aim: To identify patient factors, including gastrointestinal functions, that are predictive or associated with weight loss in response to once-daily 3 mg liraglutide administered subcutaneously (SQ) or placebo in obesity....
8.
Lucido J, Mullikin T, Abraha F, Harmsen W, Vaishnav B, Brinkmann D, et al.
Adv Radiat Oncol
. 2022 Oct;
7(6):101047.
PMID: 36188436
Purpose: This study reports on the risk of radiation-induced myelitis (RM) of the spinal cord from a large single-institutional experience with 1 to 5 fraction stereotactic body radiation therapy (SBRT)...
9.
Bakhshi Z, Yadav S, Harmsen W, Edakkanambeth Varayil J, Karls K, Tremaine W, et al.
Inflamm Bowel Dis
. 2022 Sep;
29(8):1223-1230.
PMID: 36149260
Background: Avascular necrosis (AVN) is a known adverse event associated with corticosteroid (CS) usage. Inflammatory bowel disease (IBD) is often treated with a CS for induction of remission. We sought...
10.
Maselli D, Atieh J, Clark M, Eckert D, Taylor A, Carlson P, et al.
Obesity (Silver Spring)
. 2022 Jul;
30(8):1608-1620.
PMID: 35894080
Objective: This study aimed to determine the effects of a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, liraglutide, and placebo subcutaneously over 16 weeks on weight and gastric functions and to...